Shisheng Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shisheng Zhu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Li Zhang
School of Basic Medical Sciences, Chongqing University of Chinese Medicine, Chongqing, China
3 shared publications Hongli Xiong
School of Basic Medical Sciences, Chongqing University of Chinese Medicine, Chongqing, China
2 shared publications- Jianbo Li
Chongqing Medical University
2 shared publications Bi Wei
Forensic Medicine Chongqing Key Laboratory, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China
1 shared publicationChen Qing
Forensic Medical Examination Center of Beijing Public Security Bureau, Beijing, China
1 shared publicationCongcong Zhao
Department of Forensic Medicine, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- 7 July 2026
- Published by Springer Nature in International journal of legal medicine
- Vol. 140 (6) , 1-14
Cracking the code of heatstroke: new insights into diagnosis and pathological mechanisms
As global temperatures continue to rise, the incidence and mortality rates of heatstroke (HS) have significantly increased. However, the current forensic diagnostic standards lack clear pathological criteria for deaths caused by HS, and the mechanisms of multi-organ damage induced by HS are not yet fully understood. In this study, a rat model of HS-induced death was established under conditions of 39 ± 0.5 °C and 60% ± 5% humidity. Through histopathological observation, attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) spectroscopy, and machine learning algorithms, the most severely damaged organs in HS were identified, including the hypothalamus, hippocampus, liver, and spleen. Next, we performed transcriptomic (UID mRNA-seq) and proteomic (Data-Independent Acquisition technology, DIA) analyses on the key target organ-the hypothalamus. Transcriptomic analysis revealed 447 differentially expressed genes (DEGs), with 197 genes upregulated and 250 genes downregulated. Proteomic analysis identified 692 differentially expressed proteins (DEPs), with 241 proteins upregulated and 451 proteins downregulated. Integrated multi-omics analysis indicated significant enrichment of pathways such as endoplasmic reticulum protein processing, MAPK signaling, and apoptosis following HS. Further, three key genes/proteins (Hspb1, Dnaja1, Jun) were identified and their expression changes in the hypothalamus of HS rats were validated using quantitative real-time PCR (qRT-PCR), Western blot, and immunohistochemistry. Overall, this study provides new insights into the diagnosis and mechanisms of HS and offers scientific evidence for the clinical treatment of HS. Graphical Abstract
- 7 July 2026
- Published by Springer Nature in International journal of legal medicine
- Vol. 140 (6) , 1-14
Cracking the code of heatstroke: new insights into diagnosis and pathological mechanisms
As global temperatures continue to rise, the incidence and mortality rates of heatstroke (HS) have significantly increased. However, the current forensic diagnostic standards lack clear pathological criteria for deaths caused by HS, and the mechanisms of multi-organ damage induced by HS are not yet fully understood. In this study, a rat model of HS-induced death was established under conditions of 39 ± 0.5 °C and 60% ± 5% humidity. Through histopathological observation, attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) spectroscopy, and machine learning algorithms, the most severely damaged organs in HS were identified, including the hypothalamus, hippocampus, liver, and spleen. Next, we performed transcriptomic (UID mRNA-seq) and proteomic (Data-Independent Acquisition technology, DIA) analyses on the key target organ-the hypothalamus. Transcriptomic analysis revealed 447 differentially expressed genes (DEGs), with 197 genes upregulated and 250 genes downregulated. Proteomic analysis identified 692 differentially expressed proteins (DEPs), with 241 proteins upregulated and 451 proteins downregulated. Integrated multi-omics analysis indicated significant enrichment of pathways such as endoplasmic reticulum protein processing, MAPK signaling, and apoptosis following HS. Further, three key genes/proteins (Hspb1, Dnaja1, Jun) were identified and their expression changes in the hypothalamus of HS rats were validated using quantitative real-time PCR (qRT-PCR), Western blot, and immunohistochemistry. Overall, this study provides new insights into the diagnosis and mechanisms of HS and offers scientific evidence for the clinical treatment of HS. Graphical Abstract
- Open Access
- 21 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0346628
Non-targeted metabolomics reveals myocardial metabolic alterations in epileptic rats
Sudden unexpected death in epilepsy (SUDEP) is closely associated with cardiovascular dysfunction, yet its mechanisms remain unclear. Emerging evidence suggests that epilepsy-induced cardiac dysfunction may play a central role. Metabolomics provides a powerful approach to comprehensively characterize these metabolic alterations, enabling biomarker discovery and mechanistic insight into epilepsy-related cardiac injury. Here, we used UHPLC-OE-MS-based non-targeted metabolomics to systematically characterize myocardial metabolism in epileptic rats, aiming to identify epilepsy-related myocardial metabolic biomarkers, explore their biological significance, and elucidate mechanisms underlying epilepsy-induced cardiac dysfunction. In this study, we employed UHPLC-OE-MS-based non-targeted metabolomics to systematically profile myocardial metabolic changes in a pentylenetetrazol (PTZ)-induced epileptic rat model. Myocardial tissues from epileptic and control rats were analyzed using multivariate statistical methods, including principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA), to identify significantly altered metabolites. KEGG pathway enrichment analysis was performed to elucidate the biological relevance of these metabolic disturbances. Histopathological examination revealed marked neuronal disorganization and myocardial injury in epileptic rats, characterized by cardiomyocyte swelling, nuclear pyknosis, and interstitial edema. Metabolomic analysis identified 127 differential metabolites, primarily involved in amino acid metabolism, glycerophospholipid metabolism, and energy metabolism. Notably, L-glutamine, L-phenylalanine, L-alanine, and β-alanine were significantly reduced, potentially contributing to glutamate/GABA imbalance, excitotoxicity, and oxidative stress. Additionally, dysregulated glycerophospholipids (e.g., LysoPC, PC, and PE) and altered pantothenate and CoA biosynthesis indicated compromised membrane integrity and impaired energy metabolism in epileptic myocardium. ROC analysis demonstrated excellent diagnostic performance of key metabolites (AUC > 0.98), highlighting their potential as biomarkers for epilepsy-related cardiac dysfunction.
- 21 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0346628
Open AccessNon-targeted metabolomics reveals myocardial metabolic alterations in epileptic rats
Sudden unexpected death in epilepsy (SUDEP) is closely associated with cardiovascular dysfunction, yet its mechanisms remain unclear. Emerging evidence suggests that epilepsy-induced cardiac dysfunction may play a central role. Metabolomics provides a powerful approach to comprehensively characterize these metabolic alterations, enabling biomarker discovery and mechanistic insight into epilepsy-related cardiac injury. Here, we used UHPLC-OE-MS-based non-targeted metabolomics to systematically characterize myocardial metabolism in epileptic rats, aiming to identify epilepsy-related myocardial metabolic biomarkers, explore their biological significance, and elucidate mechanisms underlying epilepsy-induced cardiac dysfunction. In this study, we employed UHPLC-OE-MS-based non-targeted metabolomics to systematically profile myocardial metabolic changes in a pentylenetetrazol (PTZ)-induced epileptic rat model. Myocardial tissues from epileptic and control rats were analyzed using multivariate statistical methods, including principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA), to identify significantly altered metabolites. KEGG pathway enrichment analysis was performed to elucidate the biological relevance of these metabolic disturbances. Histopathological examination revealed marked neuronal disorganization and myocardial injury in epileptic rats, characterized by cardiomyocyte swelling, nuclear pyknosis, and interstitial edema. Metabolomic analysis identified 127 differential metabolites, primarily involved in amino acid metabolism, glycerophospholipid metabolism, and energy metabolism. Notably, L-glutamine, L-phenylalanine, L-alanine, and β-alanine were significantly reduced, potentially contributing to glutamate/GABA imbalance, excitotoxicity, and oxidative stress. Additionally, dysregulated glycerophospholipids (e.g., LysoPC, PC, and PE) and altered pantothenate and CoA biosynthesis indicated compromised membrane integrity and impaired energy metabolism in epileptic myocardium. ROC analysis demonstrated excellent diagnostic performance of key metabolites (AUC > 0.98), highlighting their potential as biomarkers for epilepsy-related cardiac dysfunction.
- Open Access
Forensic characteristics of 38 Y-STR loci in the Hui population from Shaanxi Province, Northwest China
- Open Access
- 22 September 2023
- Published by Springer Nature in Proteome Science
- Vol. 21 (1) , 1-13
Insight into the underlying molecular mechanism of dilated cardiomyopathy through integrative analysis of data mining, iTRAQ-PRM proteomics and bioinformatics
Background: DCM is a common cardiomyopathy worldwide, which is characterized by ventricular dilatation and systolic dysfunction. DCM is one of the most widespread diseases contributing to sudden death and heart failure. However, our understanding of its molecular mechanisms is limited because of its etiology and underlying mechanisms. Hence, this study explored the underlying molecular mechanism of dilated cardiomyopathy through integrative analysis of data mining, iTRAQ-PRM proteomics and bioinformatics Methods: DCM target genes were downloaded from the public databases. Next, DCM was induced in 20 rats by 8 weeks doxorubicin treatment (2.5 mg/kg/week). We applied isobaric tags for a relative and absolute quantification (iTRAQ) coupled with proteomics approach to identify differentially expressed proteins (DEPs) in myocardial tissue. After association analysis of the DEPs and the key target genes, subsequent analyses, including functional annotation, pathway enrichment, validation, were performed. Results: Nine hundred thirty-five genes were identified as key target genes from public databases. Meanwhile, a total of 782 DEPs, including 348 up-regulated and 434 down-regulated proteins, were identified in our animal experiment. The functional annotation of these DEPs revealed complicated molecular mechanisms including TCA cycle, Oxidative phosphorylation, Cardiac muscle contraction. Moreover, the DEPs were analyzed for association with the key target genes screened in the public dataset. We further determined the importance of these three pathways. Conclusion: Our results demonstrate that TCA cycle, Oxidative phosphorylation, Cardiac muscle contraction played important roles in the detailed molecular mechanisms of DCM.
- 22 September 2023
- Published by Springer Nature in Proteome Science
- Vol. 21 (1) , 1-13
Open AccessInsight into the underlying molecular mechanism of dilated cardiomyopathy through integrative analysis of data mining, iTRAQ-PRM proteomics and bioinformatics
Background: DCM is a common cardiomyopathy worldwide, which is characterized by ventricular dilatation and systolic dysfunction. DCM is one of the most widespread diseases contributing to sudden death and heart failure. However, our understanding of its molecular mechanisms is limited because of its etiology and underlying mechanisms. Hence, this study explored the underlying molecular mechanism of dilated cardiomyopathy through integrative analysis of data mining, iTRAQ-PRM proteomics and bioinformatics Methods: DCM target genes were downloaded from the public databases. Next, DCM was induced in 20 rats by 8 weeks doxorubicin treatment (2.5 mg/kg/week). We applied isobaric tags for a relative and absolute quantification (iTRAQ) coupled with proteomics approach to identify differentially expressed proteins (DEPs) in myocardial tissue. After association analysis of the DEPs and the key target genes, subsequent analyses, including functional annotation, pathway enrichment, validation, were performed. Results: Nine hundred thirty-five genes were identified as key target genes from public databases. Meanwhile, a total of 782 DEPs, including 348 up-regulated and 434 down-regulated proteins, were identified in our animal experiment. The functional annotation of these DEPs revealed complicated molecular mechanisms including TCA cycle, Oxidative phosphorylation, Cardiac muscle contraction. Moreover, the DEPs were analyzed for association with the key target genes screened in the public dataset. We further determined the importance of these three pathways. Conclusion: Our results demonstrate that TCA cycle, Oxidative phosphorylation, Cardiac muscle contraction played important roles in the detailed molecular mechanisms of DCM.
- Open Access
- 21 September 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-9
UPLC/Q-TOF MS-Based Urine Metabonomics Study to Identify Diffuse Axonal Injury Biomarkers in Rat
Diffuse axonal injury (DAI) represents a frequent traumatic brain injury (TBI) type, significantly contributing to the dismal neurological prognosis and high mortality in TBI patients. The increase in mortality can be associated with delayed and nonspecific initial symptoms in DAI patients. Additionally, the existing approaches for diagnosis and monitoring are either low sensitivity or high cost. Therefore, novel, reliable, and objective diagnostic markers should be developed to diagnose and monitor DAI prognosis. Urine is an optimal sample to detect biomarkers for DAI noninvasively. Therefore, the DAI rat model was established in this work. Meanwhile, the ultraperformance liquid chromatography quadrupole-time-of-flight hybrid mass spectrometry- (UPLC/Q-TOF MS-) untargeted metabolomics approach was utilized to identify the features of urine metabolomics to diagnose DAI. This work included 57 metabolites with significant alterations and 21 abnormal metabolic pathways from the injury groups. Three metabolites, viz., urea, butyric acid, and taurine, were identified as possible biomarkers to diagnose DAI based on the great fold changes (FCs) and biological functions during DAI. The present study detected several novel biomarkers for noninvasively diagnosing and monitoring DAI and helped understand the DAI-associated metabolic events.
- 21 September 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-9
Open AccessUPLC/Q-TOF MS-Based Urine Metabonomics Study to Identify Diffuse Axonal Injury Biomarkers in Rat
Diffuse axonal injury (DAI) represents a frequent traumatic brain injury (TBI) type, significantly contributing to the dismal neurological prognosis and high mortality in TBI patients. The increase in mortality can be associated with delayed and nonspecific initial symptoms in DAI patients. Additionally, the existing approaches for diagnosis and monitoring are either low sensitivity or high cost. Therefore, novel, reliable, and objective diagnostic markers should be developed to diagnose and monitor DAI prognosis. Urine is an optimal sample to detect biomarkers for DAI noninvasively. Therefore, the DAI rat model was established in this work. Meanwhile, the ultraperformance liquid chromatography quadrupole-time-of-flight hybrid mass spectrometry- (UPLC/Q-TOF MS-) untargeted metabolomics approach was utilized to identify the features of urine metabolomics to diagnose DAI. This work included 57 metabolites with significant alterations and 21 abnormal metabolic pathways from the injury groups. Three metabolites, viz., urea, butyric acid, and taurine, were identified as possible biomarkers to diagnose DAI based on the great fold changes (FCs) and biological functions during DAI. The present study detected several novel biomarkers for noninvasively diagnosing and monitoring DAI and helped understand the DAI-associated metabolic events.
- Open Access
- 2 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 10045
Revealing the Therapeutic Targets and Mechanism of Ginsenoside Rg1 for Liver Damage Related to Anti-Oxidative Stress Using Proteomic Analysis
Ginsenoside Rg1 is an important active substance isolated from the root of ginseng. In previous studies, Rg1 has shown excellent therapeutic effects in antioxidant, anti-inflammatory, and metabolic modulation. However, the therapeutic targets of Rg1 are still unknown. In this study, we investigated the therapeutic effects of Rg1 on oxidative stress-related liver damage. The oxidative stress damage model was achieved by intraperitoneal injection of D-galactose (D-gal) for 42 consecutive days in C57BL/6J mice. Rg1 treatment started on Day 16. Body weight, liver weight, degree of hepatic oxidative stress damage, serum lipid levels, and hepatic lipid and glucose metabolism were measured. Proteomics analysis was used to measure liver protein expression. The differential expression proteins were analyzed with bioinformatics. The results showed that Rg1 treatment attenuated liver damage from oxidative stress, reduced hepatic fat accumulation, promoted hepatic glycogen synthesis, and attenuated peripheral blood low-density lipoprotein (LDL), cholesterol (CHO), and triglycerides (TG) levels. Proteomic analysis suggested that Rg1 may regulate hepatocyte metabolism through ECM–Receptor, the PI3K-AKT pathway. The epidermal growth factor receptor (EGFR) and activator of transcription 1 (STAT1) may be the key protein. In conclusion, this study provides an experimental basis for further clarifying the specific mechanism of Rg1 in the treatment of oxidative stress damage-related liver disease.
- 2 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 10045
Open AccessRevealing the Therapeutic Targets and Mechanism of Ginsenoside Rg1 for Liver Damage Related to Anti-Oxidative Stress Using Proteomic Analysis
Ginsenoside Rg1 is an important active substance isolated from the root of ginseng. In previous studies, Rg1 has shown excellent therapeutic effects in antioxidant, anti-inflammatory, and metabolic modulation. However, the therapeutic targets of Rg1 are still unknown. In this study, we investigated the therapeutic effects of Rg1 on oxidative stress-related liver damage. The oxidative stress damage model was achieved by intraperitoneal injection of D-galactose (D-gal) for 42 consecutive days in C57BL/6J mice. Rg1 treatment started on Day 16. Body weight, liver weight, degree of hepatic oxidative stress damage, serum lipid levels, and hepatic lipid and glucose metabolism were measured. Proteomics analysis was used to measure liver protein expression. The differential expression proteins were analyzed with bioinformatics. The results showed that Rg1 treatment attenuated liver damage from oxidative stress, reduced hepatic fat accumulation, promoted hepatic glycogen synthesis, and attenuated peripheral blood low-density lipoprotein (LDL), cholesterol (CHO), and triglycerides (TG) levels. Proteomic analysis suggested that Rg1 may regulate hepatocyte metabolism through ECM–Receptor, the PI3K-AKT pathway. The epidermal growth factor receptor (EGFR) and activator of transcription 1 (STAT1) may be the key protein. In conclusion, this study provides an experimental basis for further clarifying the specific mechanism of Rg1 in the treatment of oxidative stress damage-related liver disease.
- Open Access
- 1 January 2017
- Published by Medknow in Journal of Forensic Science and Medicine
- Vol. 3 (3) , 177
Case of fatal air embolism during double-J ureteral stent placement
Air embolism is a severe and fatal complication, but it is very rare during transurethral surgery. This report describes a case of air embolism during double-J ureteral stent placement in a 45-year-old woman. During ureteroscopy, a sudden decrease in oxygen saturation and end-expiratory carbon dioxide pressure and cyanosis of the face were observed. Subsequent echocardiography confirmed an air embolism by detecting bubbles in the heart. Despite resuscitative measures, the patient died rapidly. Detailed autopsy was performed to clarify the cause of death and the route of air entering into the circulatory system. The report presented here reminds urologists and pathologists that air embolism can occur during double-J ureteral stent placement and offers some suggestions regarding identification of air embolism at autopsy.
- 1 January 2017
- Published by Medknow in Journal of Forensic Science and Medicine
- Vol. 3 (3) , 177
Open AccessCase of fatal air embolism during double-J ureteral stent placement
Air embolism is a severe and fatal complication, but it is very rare during transurethral surgery. This report describes a case of air embolism during double-J ureteral stent placement in a 45-year-old woman. During ureteroscopy, a sudden decrease in oxygen saturation and end-expiratory carbon dioxide pressure and cyanosis of the face were observed. Subsequent echocardiography confirmed an air embolism by detecting bubbles in the heart. Despite resuscitative measures, the patient died rapidly. Detailed autopsy was performed to clarify the cause of death and the route of air entering into the circulatory system. The report presented here reminds urologists and pathologists that air embolism can occur during double-J ureteral stent placement and offers some suggestions regarding identification of air embolism at autopsy.